A detailed history of Opal Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Opal Wealth Advisors, LLC holds 5,171 shares of ABBV stock, worth $1.01 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
5,171
Previous 5,061 2.17%
Holding current value
$1.01 Million
Previous $921,000 3.8%
% of portfolio
0.29%
Previous 0.31%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$154.79 - $180.76 $17,026 - $19,883
110 Added 2.17%
5,171 $886,000
Q1 2024

Apr 11, 2024

SELL
$159.82 - $182.1 $121,463 - $138,396
-760 Reduced 13.06%
5,061 $921,000
Q4 2023

Jan 19, 2024

SELL
$137.6 - $154.97 $133,059 - $149,855
-967 Reduced 14.25%
5,821 $902,000
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $10,420 - $12,062
78 Added 1.16%
6,788 $1.01 Million
Q2 2023

Jul 27, 2023

BUY
$132.51 - $164.9 $80,698 - $100,424
609 Added 9.98%
6,710 $904,000
Q1 2023

Apr 19, 2023

BUY
$144.61 - $166.54 $108,023 - $124,405
747 Added 13.95%
6,101 $972,000
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $15,905 - $19,075
115 Added 2.2%
5,354 $865,000
Q3 2022

Oct 17, 2022

BUY
$134.21 - $153.93 $43,215 - $49,565
322 Added 6.55%
5,239 $703,000
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $9,495 - $12,072
69 Added 1.42%
4,917 $753,000
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $3,563 - $4,421
27 Added 0.56%
4,848 $786,000
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $20,519 - $25,962
191 Added 4.13%
4,821 $653,000
Q3 2021

Nov 05, 2021

SELL
$106.4 - $120.78 $17,449 - $19,807
-164 Reduced 3.42%
4,630 $499,000
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $25,986 - $28,950
247 Added 5.43%
4,794 $540,000
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $17,186 - $18,920
168 Added 3.84%
4,547 $492,000
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $352,465 - $475,865
4,379 New
4,379 $469,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Opal Wealth Advisors, LLC Portfolio

Follow Opal Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opal Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Opal Wealth Advisors, LLC with notifications on news.